MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited)
MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]
The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest